Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of the BBIBP-CorV COVID-19 vaccine in adolescents in Thailand
TCTR20210920005Phase 2Recruiting
- Sponsor
- Chulabhorn Royal Academy
- Start
- Sep 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Chulabhorn Royal Academy. Started Sep 2021; status: recruiting.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210920005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210920005.